Vincynon injection 250mg/2ml Vinphaco Short -term treatment of blood loss in polyphony (2 blisters x 5 tubes x 2ml/tube)

Dosage form Box of 2 blisters x 5 tubes x 2ml/tube
Specifications Etamsylat

Ingredient

Composition informationContent
Etamsylat250

Uses

Indications

Vincynon 250 mg/2ml drug is indicated in the following cases:

  • Short -term treatment of blood loss in multi -menstruation. g). The drug maintains the stability of the capillary wall and adjusts the unusual adhesion of platelets. Etamsylate is used to prevent and handle bleeding in small blood vessels.

    Pharmacokinetics

    absorption

    Absorb 1 hour after intravenous injection or intramuscularly 500 mg of Etamsylate, plasma concentration is 30 μg/ml.

    Distribution

    The ratio of binding with plasma proteins is about 95%. Etamsylate is distributed into breast milk.

    Elimination

    Etamsylate is excreted mainly in the form of unchanged urine (> 80%). Etamsylate waste sale time in plasma when intravenous injection is 1.9 hours and when intramuscularly is 2.1 hours.

    • Before taking Vincynon injection 250mg/2ml Vinphaco Short -term treatment of blood loss in polyphony (2 blisters x 5 tubes x 2ml/tube)

    How to use

    Vincynon 250 mg/2ml for injection.

    Dosage

    adults

    Control bleeding after surgery:

    Can be intramuscularly or static with adult dose is 250 mg - 500 mg. This dose can be repeated after 4 - 6 hours, when needed.

  • For emergency: Intramuscularly or intravenously 500 mg - 750 mg once, 3 times a day.

    Use 1/2 adult dose.

    Preventing and treating bleeding around or in ventricular brain in infants with very low weight:

    Intravenous or intramuscular injection of 12.5 mg/kg body weight within 1 hour after birth, then every 6 hours repeats 1 time within 4 days to a total dose of 200 mg/kg.

    Note: It is possible to dissolve the injection solution in 1 cup of water to drink, which can also be used to bandage on the spot.

    Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when using overdose?

    No report.

    What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Do not drink twice as prescribed.

    • Side Effects

    When using Vincynon 250 mg/2ml, you may experience unwanted effects (ADR).

    Common, ADR> 1/100

  • Digestive: Nausea, vomiting, diarrhea.
    • nerve: headache, fever.

    Uncommon, 1/1000

  • Increase the ratio of deep vein thrombosis in people with vaginal surgery.
    • Cardiovascular: Hypotension.

    Skin.

    Instructions on how to handle ADR

    Patients experience symptoms such as headaches, ban: need to reduce the dose.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    Contraindicated

    Vincynon drug 250 mg/2ml contraindicated in the following cases:

  • Hypersensitivity to Etamsylat or any ingredient of the drug.

    Be cautious when using

    Caution when using Etamsylate for people who are or have a history of intravenous inflammation (such as stroke, pulmonary artery, deep vein obstruction) because it is associated with an increase in the rate of deep vein thrombosis in people with vaginal surgery.

    Be cautious with asthma patients, allergies or a history of allergic reactions to drugs due to Etamsylate preparations containing sodium sulfit that can cause or aggravate anaphylactic reaction

    Precautions when used for patients with renal impairment due to drugs except for most of the kidneys in constant form.

    The ability to drive and operate machinery

    The drug can cause effects such as headache, nausea. Therefore, patients should not drive or operate machinery if they experience these side effects when taking the drug.

    Pregnancy

    There is no report.

    The period of breastfeeding

    should not be used for women who are breastfeeding because the drug is distributed through breast milk.

    Drug interaction

    No report.

    • Storage

    Store in a dry place, temperature below 30ºC, avoid light.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords